医学
宫颈癌
人口
肺癌
肿瘤科
癌症
内科学
环境卫生
作者
Krishnansu S. Tewari,Bradley J. Monk,Ignace Vergote,Austin Miller,Andréia Cristina de Melo,Hee‐Seung Kim,Yong Man Kim,Alla Lisyanskaya,Vanessa Samouëlian,Domenica Lorusso,Fernanda Damian,Chih‐Long Chang,Evgeniy A. Gotovkin,Shunji Takahashi,Daniella Ramone,Joanna Pikiel,Beata Maćkowiak-Matejczyk,Eva Maria Guerra Alía,Nicoletta Colombo,Yulia Makarova
标识
DOI：10.1056/nejmoa2112187
摘要
Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)–blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
Criminology34
GingerF
你嵙这个期刊没买
小药童
YifanWang
Smar_zcl
soler
VDC
pcr163
sissiarno
heavenhorse
Alex
无极微光
斯文败类
wlscj
tuanheqi
wop111
正己化人
Leon
eric888
Lm
优美的小笨蛋
yuchuan
皖公网安备34019202002308
